PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2015 | 09 | 1 |
Tytuł artykułu

Comparison of nutrition knowledge in patients with type 1 and type 2 diabetes

Treść / Zawartość
Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
Introduction. Diabetes as a non-infectious chronic metabolic disease is a problem of the contemporary world, including Poland. Behaviour therapy plays an important role in its treatment, i.e. proper diet and regular physical activity. Patient’s knowledge of nutrition principles is also an essential complement to the treatment, reducing the risk of late complications of diabetes. Objective. Assessment of the nutrition knowledge of patients with type 1 and type 2 diabetes. Materials and method. The study involved 300 randomly selected patients from Rzeszów and the surrounding area (135 patients with type 1 diabetes and 165 patients with type 2 diabetes) aged 8–78.The analysis was made using a survey questionnaire prepared by the authors of the study, conducted in the period July – December 2011. Results. The survey revealed that patients with type 1 diabetes have greater nutrition knowledge and knowledge about diabetes than patients with type 2 diabetes. On the other hand, they are less likely to comply with the recommendations of the diet prescribed by a doctor or a dietician. Conclusions. Patients with diabetes, regardless of age, type of diabetes, gender, or disease duration require continuous broadening of diabetes knowledge. Systematic training will teach patients proper eating habits related to their diet and lifestyle.
Wydawca
-
Rocznik
Tom
09
Numer
1
Opis fizyczny
p.23-26,fig.,ref.
Twórcy
autor
  • Medical Faculty University of Rzeszow, Warszawska 26a, 35-205 Rzeszow, Poland
  • Faculty of Public Health, Medical University of Silesia, Katowice, Poland
autor
  • Medical Faculty University of Rzeszow, Warszawska 26a, 35-205 Rzeszow, Poland
autor
  • Medical Faculty University of Rzeszow, Warszawska 26a, 35-205 Rzeszow, Poland
Bibliografia
  • 1. Pietrzykowska E, Zozulińska D, Wierusz-Wysocka B. Jakość życia chorych na cukrzycę. Pol Merk Lek. 2007; 23: 311–314 (in Polish).
  • 2. Kinalska I. Otyłość a cukrzyca – problemy terapeutyczne. Przegl Kardiodiabetol. 2008; 3(4): 296–301 (in Polish).
  • 3. International Diabetes Federation. IDF Diabetes Atlas update poster, 6th edn. Brussels, Belgium: International Diabetes Federation, 2014.
  • 4. Jarosz-Chobot P, Otto-Buczkowska E. Epidemiologia cukrzycy typu 1. Przegl Pedriatr. 2009; 39(4): 229–234 (in Polish).
  • 5. Wittek A, Strojek K, Grzeszczak W. Prevalence of diabetes and cardiovascular risk factor in industrial area in Southern Poland. ExpClin Endocrinol Diabetes. 2009; 117: 350–353.
  • 6. Currie CJ, Kraus D, Morgan CL, Gill L, Stott NC, Peters JR. NHS acute sector expenditure for diabetes: the present, future, and excess in-patientcost of care. Diabet Med. 1997; 14: 686–692.
  • 7. Tatoń J, Kuczerowski R, Kowrach M. Kliniczna charakterystyka zespołu metabolicznego. Przew Lek. 2003; 6(4): 58–65 (in Polish).
  • 8. Czech A, Cypryk K, Czupryniak L, et al. Zalecenia kliniczne dotyczące postępowania u chorych na cukrzycę, Stanowisko PolskiegoTowarzystwa Diabetologicznego. Diabetologia Kliniczna 2013; 2(supl. A): A1-A70 (in Polish).
  • 9. American Diabetes Association: Standards of medical care in Diabetes 2013. Diabetes Care 2006; 29: 2140–2157.
  • 10. Cheetin CC, Sharps SJ, Wexler DJ, et al. Dietary Intake of Eicosapentaenoic and Docosahexaenoic Acid and Diabetic Nephropathy: Cohort Analysisof the Diabetes Control and Complications Trial. Diabetes Care 2010;33: 1454–1456.
  • 11. Jarosz M, Kłosiewicz-Latoszek L. Cukrzyca: zapobieganie i leczenie. Warszawa, PZWL, 2007 (in Polish).
  • 12. Zielke M, Reguła J. Sposób żywienia i aktywność fizyczna a wskaźniki antropometryczne chorych na cukrzycę typu 2. Żyw Człow Metab.2007; 34: 1131–1137 (in Polish).
  • 13. Kogan AJ. Overcoming obstacles to effective care of type 2 diabetes. Am J Manag Care. 2009; 15: 255–262.
  • 14. Hernández-Ronquillo L, Téllez-Zenteno JF, Garduńo-Espinoza J, González-Acevez E. Factors associated with therapy noncompliancein type-2 diabetes patients. Salud. Publica Mex. 2003; 45: 191–197.
  • 15. Peyrot M, Rubin RR, Lauritzen T, et al. Resistance to insulin therapy among patients and providers results of the cross- -national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care 2005; 28,2673–2679.
  • 16. Karakiewicz B, et al. Znaczenie edukacji zdrowotnej w pracy z pacjentem z cukrzycą typu 2. Ann UMCS. 2004; 59, 14: 449–455 (in Polish).
  • 17. Dailey G, Kim MS, Lian JF. Patient compliance and persistence with anti hyperglycemic therapy: evaluation of a population of type 2 diabeticpatients. J Inter Med Res. 2002; 30: 71–79.
  • 18. Dezii CM, Kawabata H, Tran M. Effects of once-daily and twice-daily dosing on adherence with prescribet glipizide oral therapy for type 2diabetes. South Med J. 2002; 95: 68–71.
  • 19. Kahn CR, Weir GC, King GL, et al. Joslin’s Diabetes Mellitus. Ed. 14th. Lippincott Williams & Wilkins, 2004: 597–610.
  • 20. WHO Expert Committee on Diabetes Mellitus. Education. Second report. World Health Organ Tech Rep Ser. 1980; 646: 1–80.
  • 21. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetesmellitus. N Engl J Med. 1993; 329: 977–986.
  • 22. UK Prospective Diabetes Study (UKPDS) Group. Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837–853.
  • 23. Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005; 365: 1333–1346.
  • 24. Johnson ST, Bell GJ, MCcargar LJ, Welsh RS, Bell RC. Improved cardiovascular health following a progressive walking and dietary intervention for type 2 diabetes. Diabetes Obes Metab. 2009; 11: 836– 843.
  • 25. Gutschall MP, Miller CK, Mitchell DC, Lawrence FR. A randomized behavioral trial targeting glycemic index improves dietary, weight and metabolic outcomes in patients with type 2 diabetes. Public Health Nutr. 2009; 23: 1–9.
Typ dokumentu
Bibliografia
Identyfikatory
Identyfikator YADDA
bwmeta1.element.agro-2dd5bd96-b4f3-4432-9e5a-7c6cd9626fe9
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.